EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides

Victoria Garfinkel iD, Joan S Reisch, Heather Woodworth Goff iD

Photodermatology, Photoimmunology & Photomedicine · 2024

DOI: 10.1111/phpp.13009 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, 2024. Verfasst von Victoria Garfinkel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Mycosis Fungoides, Ultraviolet Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study addresses the gap in research comparing the effectiveness between home and in‐office narrowband ultraviolet B (NB‐UVB) phototherapy for the treatment of mycosis fungoides (MF). Elderly and disabled patients with this condition disproportionally lack access to home units due to insurance denial. Materials and Methods A retrospective review included patients diagnosed with MF or Sezary syndrome who underwent either in‐office or home UVB between 2016 and 2023. Eighty‐four patients used home NB‐UVB, while 75 used in‐office. Clinical characteristics, treatment response, and access were evaluated.

Results

Overall, there was no significant difference in response rates between home and in‐office NB‐UVB phototherapy. Subgroup analysis based on adjuvant treatment revealed a significant difference in clinical response rates for patients using NB‐UVB with topicals ( p = 0.008) and NB‐UVB with multiple systemic therapies ( p = 0.04). Financial and time constraints were the most common cause of treatment discontinuation for in‐office patients (28%).

Conclusions

The effectiveness of home NB‐UVB treatment is comparable, if not superior, to in‐office treatment, likely attributed to treatment ease in access and compliance. Medicare and other health insurance companies should expand coverage to include home‐based phototherapy for patients with MF, a potentially fatal cancer with a relative paucity of effective alternate therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesUltraviolet TherapyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultSkin NeoplasmsAged, 80 and over

Stichwörter der Autor:innen

efficacyhome‐based narrowband ultraviolet B phototherapymycosis Fungoides

Autor:innen und Institutionen

  • Medical School, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Biostatistics, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Victoria Garfinkel, Heather Woodworth Goff

Zitieren

APA

Garfinkel, V., Reisch, J. S., & Goff, H. W. (2024). A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.13009

Vancouver

Garfinkel V, Reisch JS, Goff HW. A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.13009

BibTeX
@article{Garfinkel2024,
  author = {Garfinkel, Victoria and Reisch, Joan S and Goff, Heather Woodworth},
  title = {A Retrospective Comparison Between Home and in‐Office NB ‐ UVB Efficacy for Patients With Mycosis Fungoides},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2024},
  doi = {10.1111/phpp.13009}
}
Kostenlos starten →